Skip to main content

COVID-19 Funding Opportunities

ORSP has identified the following funding opportunities related to COVID-19. If interested, please submit an NOI: research.utep.edu/noi


UTEP invites researchers are to submit COVID-19 related research proposals to the consortium, which will then be reviewed for matching with computing resources. An expert panel comprised of top scientists and computing researchers will work with proposers to assess the public health benefit of the work, with emphasis on projects that can ensure rapid results. The COVID-19 High Performance Computing Consortium helps aggregate computing capabilities from the world's most powerful and advanced computers to help COVID-19 researchers execute complex computational research programs to help fight the virus. Applications are accepted at any time.​


Agency Program Due Date Abstract Type
United States Department of Health and Human Services (HHS)

Biomedical Advanced Research and Development Authority (BARDA) Novel Coronavirus EZ-BAA

Rolling Seeks research for molecular diagnostic assays, point-of-care detection, screening models, and other topics pertaining to COVID-19. FED

White House Office of Science and Technology Policy

COVID-19 High Performance Computing (HPC) Consortium

This consortium is a unique private-public effort to bring together federal government, industry, and academic leaders to execute complex computational research programs. Researchers are invited to submit COVID-19 related research proposals to the consortium via this online portal, which will then be reviewed for matching with computing resources from one of the partner institutions. An expert panel comprised of top scientists and computing researchers will work with proposers to assess the public health benefit of the work, with emphasis on projects that can ensure rapid results.
XSEDE Website

FED

Food and Drug Administration (FDA)/Office of the Chief Scientist (OCS)

and Center for Drug Evaluation and Research (CDER)

Drug Development Science Support (U01)

The Food and Drug Administration (FDA) Office of the Chief Scientist (OCS) and FDA Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider applications for the award of a co-operative agreement to protect and promote the health of the American public by creating new, applied scientific knowledge, tools, standards and approaches to evaluate products more effectively, predictably and efficiently.

FED

National Endowment for the Humanities (NEH)

Funding for NEH Applicants and Grantees Impacted by the Coronavirus


NEH plans to announce funding opportunities for eligible organizations seeking support for at-risk humanities positions and projects at cultural nonprofits  that have been impacted by the coronavirus. 

FED

Office of the Assistant Secretary for Preparedness and Response (ASPR)

Public Health Emergency development of new medical countermeasures

Public Health Emergency development of new medical countermeasures

FED

National Institutes of Health (NIH)

Agency for Healthcare Research and Quality (AHRQ)

 Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19

The health systems research community should prepare to submit applications to AHRQ to fund critical research focused on evaluating topics such as innovations and challenges encountered in the rapid expansion of telemedicine in response to COVID-19, effects on quality, safety, and value of health system response to COVID-19, and the role of primary care practices and professionals during the COVID-19 epidemic.  AHRQ is particularly interested in understanding how digital health innovations contributed to health system and healthcare professional innovation and challenges and solutions to meeting the needs of vulnerable populations including older adults, people living with multiple chronic conditions, rural communities, and uninsured and underinsured populations.

SUPPL

 National Institutes of Health (NIH)

Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency caused by Coronavirus Disease 2019 (COVID-19)

To be announced

The purpose of this Notice is to extend the data-harmonization effort at the National Institute of Mental Health (NIMH) announced in NOT-MH-15-009 to research protocols pertaining to the public health emergency caused by Coronavirus Disease 2019 (COVID-19), the disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

SUPPL

National Institutes of Health (NIH)

R01, R21, SBIR/STTR for COVID-19

Varies by program

Three of the largest NIH parent/umbrella funding mechanisms have now been updated to indicate that applications pertaining to COVID-19 research are welcomed.

FED
National Institutes of Health (NIH)

Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)

Rolling The National Institute of Allergy and Infectious Diseases (NIAID) has released a new funding opportunity to provide personal protective equipment to directly support the needs of the NIAID’s vaccine and treatment clinical trials and clinical studies for COVID-19. Eligibility is limited to recipients conducting COVID-related clinical research and clinical studies supported by NIAID’s emergency appropriation provided by the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 and the Coronavirus Aid, Relief and Economic Security (CARES) Act. FED

National Institutes of Health (NIH)

Agency for Healthcare Research and Quality (AHRQ)

Special Emphasis Notice (SEN): AHRQ Announces Interest in Research on Improving Organizational Health Literacy to Prevent and Manage Chronic Disease


 This Special Emphasis Notice (SEN) highlights AHRQ’s interest in receiving applications focusing on primary and other ambulatory care settings that: 1) test approaches to integrating organizational health literacy strategies that make it easier for people, especially those with limited health literacy, to take action to prevent and manage their chronic conditions, including diabetes, and 2) spread and scale previously tested organizational health literacy strategies to settings that serve a high proportion of patients with limited health literacy, and/or socioeconomically disadvantaged people.AHRQ is interested in applications that address:

  • Which approaches for implementing organizational health literacy strategies, and in which ambulatory settings, are effective in improving prevention and management of chronic diseases for diverse people with limited health literacy
  • How healthcare organizations can best adopt, adapt, implement, and scale and spread health literacy strategies to improve prevention and management of diabetes and other chronic diseases for people with limited health literacy
FED

National Institutes of Health (NIH)

NIH Rapid Acceleration of Diagnostics (RADx) Initiative for COVID-19

Rolling

 

The stimulus investment supercharges NIH’s strong research efforts already underway focused on prevention and treatment of COVID-19, including the recently announced planned Accelerating COVID-19 Therapeutic Interventions and Vaccines public-private partnership to coordinate the international research response to the pandemic.  

As part of this initiative, NIH is urging all scientists and inventors with a rapid testing technology to compete in a national COVID-19 testing challenge for a share of up to $500 million over all phases of development. The technologies will be put through a highly competitive, rapid three-phase selection process to identify the best candidates for at-home or point-of-care tests for COVID-19. 

FED

 

National Institutes of Health (NIH)

National Institute of Allergy and Infectious Diseases (NIAID)

Emergency awards – rapid investigation of severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 (R01 clinical trial not allowed)

These support research on SARS-CoV-2 and COVID-19. The maximum project period is five years.

FED
National Institutes of Health (NIH)


National Center for Advancing Translational Sciences(NCATS)

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus

01/02/2022

NCATS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the COVID-19. NCATS is especially interested in research in the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and advance the translation of research findings into diagnostics, therapeutics, and vaccines.

SUPPL
National Institutes of Health (NIH)

National Cancer Institute (NCI)

National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)

The National Cancer Institute (NCI) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and the effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), on cancer, and vice versa. Topics of specific interest to NCI include understanding the basic mechanisms of interaction between SARS-CoV-2 and cancer cells, co-morbidities of cancer and SARS-CoV-2 infection (especially in disparately affected patient populations), and the impacts on treatment and clinical outcomes of SARS-CoV-2 infected persons in the context of cancer. FED

Agency for Health Care Research and Quality (AHRQ) 

 

Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement – Clinical Trial Optional)

Varies

 

For grants that were previously funded under FOAs supported by Patient Centered Outcome Research Trust Fund (PCOR TF) dollars, please see FOA number PA-20-072.

For grants that were funded using AHRQ Health Service Research (HSR) dollars, please see FOA number PA-20-070.

Topics: Applications must be responsive to AHRQ’s mission. AHRQ’s Research Priority Areas are:

  1. Research to improve health care patient safety.
  2. Harnessing data and technology to improve health care quality and patient outcomes and to provide a 360-degree view of the patient.
  3. Research to increase accessibility and affordability of health care by examining innovative market approaches to care delivery and financing.
SUPPL

National Science Foundation (NSF)

Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19 Rolling

NSF is seeking Phase I SBIR/STTR proposals focused on the development and deployment of new technologies, products, processes, and services with the potential to positively impact the nation’s and world’s ability to respond to the COVID-19 crisis.

Topics: Artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations.
FED

National Science Foundation (NSF)

Dear Colleague Letter on the Coronavirus

Rolling

The NSF encourages investigators to use existing NSF funding mechanisms to submit proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge.For proposals of up to $200K, NSF encourages using the Rapid Response Research (RAPID) funding mechanism, which allows NSF to receive and review proposals having a severe urgency.

FED
National Science Foundation (NSF) Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) Rolling

The Office of Advanced Cyberinfrastructure (OAC) within the Directorate for Computer and Information Science and Engineering is inviting RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities.

FED

Department of Commerce (DOC)

National Institute of Standards and Technology (NIST)

NIST Manufacturing USA National Emergency Assistance Program Rolling

Topic: NIST invites Manufacturing USA institutes to propose high-impact projects designed to respond to the COVID-19 pandemic

FED

Department of Defense (DOD)

Congressionally Directed Medical Research Programs (CDMRP)

Congressionally Directed Medical Research Programs (CDMRP) Varies

 

Three of the FY20 PRMRP mechanisms are focused on Emerging Viral Diseases and Respiratory Health.

Mechanisms:

FED

Department of Defense (DOD)

Medical Technology Enterprise Consortium (MTEC)

Development of Treatments for COVID-19

To be announced

MTEC is an enterprise partnership in collaboration with industry and academia to facilitate research and development activities, in cooperation with the U.S. Army Medical Research and Development Command (USAMRDC) and other DoD agencies in the biomedical sciences MTEC membership is not required for proposal submission, but it is required for an award.

FED

Department of Defense (DOD)

Medical Technology Enterprise Consortium (MTEC)

National Emergency Telecritical Care Network (NETCCN) Project To be announced

This program is specifically focused on preparation for COVID-19 related critical care capability shortages.  Although the United States has more critical care beds per capita than other developed nations, emerging national and international experience with COVID-19-related critical illness suggests a high level of oncoming system stress on critical care resources and a likely potential for intensive care unit (ICU) beds and care teams to be overwhelmed.

 

FED

Department of Energy (DOE)

DOE COVID-19 Response Letter DOE encourages you to consider scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure. Please send research questions that the scientific community may address with DOE resources by email to SC.DCL@science.doe.gov. More information can be found in the Dear Colleague Letter on DOE’s Coronavirus Resources Hub. FED

Department of Energy (DOE)

COVID-19 High Performance Computing Consortium  Rolling Invites researchers are to submit COVID-19 related research proposals to the consortium, which will then be reviewed for matching with computing resources. An expert panel comprised of top scientists and computing researchers will work with proposers to assess the public health benefit of the work, with emphasis on projects that can ensure rapid results. The COVID-19 High Performance Computing Consortium helps aggregate computing capabilities from the world's most powerful and advanced computers to help COVID-19 researchers execute complex computational research programs to help fight the virus.  FED

US Department of Agriculture (USDA)

National Institute of Food and Agriculture (NIFA) Varies In response to the current need for more COVID-19 information, certain NIFA programs will allow submission of COVID-19 relevant projects outside of their normal deadlines.  Frequently Asked Questions regarding COVID-19 submissions can be found below. FED
US Department of Agriculture (USDA) Agriculture and Food Research Initiative (AFRI) Varies

Topics: Focus areas of interest include, but are not limited to the following:

  • Animal Nutrition, Growth and Lactation (A1231)
  • Critical Agricultural Research and Extension (CARE) (A1701)
  • Diseases of Agricultural Animals (A1221)
  • Food Safety and Defense (A1332)
  • Foundational Knowledge of Plant Products (A1103)
  • Economics, Markets, and Trade (A1641)
FED

National Institute of Standards and Technology (NIST)

NIST Manufacturing USA National Emergency Assistance Program Rolling Projects should focus on responding to the COVID-19 pandemic. Projects may include medical countermeasures; non-medical countermeasures; leveraging institute capabilities to strengthen state and community resilience; grants to companies and technical support to accelerate productions of critical materials, equipment, and supplies; creation of additional production facilities; technology roadmapping for pandemic response and recovery; reshoring the manufacture of critical conventional drugs and ensuring supply chain for critical materials related to pandemic response; or workforce development and training for a skilled advanced manufacturing workforce. FNDN

Bill & Melinda Gates Foundation

COVID-19 Therapeutics Accelerator

 The COVID-19 Therapeutics Accelerator is a collaborative effort to research, develop and bring effective treatments to market quickly and accessibly.Currently there are no broad-spectrum antivirals or immunotherapies available for the fight against emerging pathogens, and no proven treatments approved for use against COVID-19.

The COVID-19 Therapeutics Accelerator is a philanthropic initiative designed to coordinate R&D efforts, remove barriers to drug development and scale up treatments to address the pandemic.We can combat COVID-19 together. Sharing knowledge and resources across governments, the private sector, academia and philanthropy can accelerate the timeline for bringing treatments to market. We are actively seeking and welcoming new partners and collaborators in this effort

FNDN

California Institute for Regenerative Medicine

Special Call for COVID-19 Projects Rolling, Bi-monthly

Topics: Discovery, preclinical, and clinical trial stage projects that could quickly advance treatments to COVID-19 patients in need.

FNDN

Emergent Ventures

Fast Grants Rolling

Fast Grants are available exclusively to PIs at academic institutions already working on COVID-19 related projects that could help with the pandemic within the next six months.

Topics: All COVID-19 related science
FNDN

Wellcome Trust

Epidemic Preparedness - COVID-19 funding call To be announced

Wellcome, in partnership with the Department for International Development, invites expressions of interest for its epidemic preparedness - COVID-19 funding call. This aims to strengthen the evidence base to better prevent and control coronavirus (COVID-19) epidemics and increase research and response capacity. 

FNDN

Open Society Foundations

Aid People Hardest Hit by COVID-19 Pandemic

To be announced 

 

The Open Society Foundations are making an investment to combat the devastation in the wake of the coronavirus—focusing on communities too often left out and left back by government policy.

FNDN
American Documentary COVID-19 Artist Emergency Fund Rolling

This COVID-19 Artist Emergency Fund will provide rapid response grants up to $500 to assist artists with basic needs including food, immediate health needs and insurance premiums. Applications are now open and will be reviewed on a rolling basis until the fund is expired. These one-time grants are a direct response to concerns about sustainability in the documentary field, with overall lack of adequate healthcare alongside loss of livelihood due to canceled production, festivals and theatricals.

FNDN

 Home Grown

Home-Based Child Care Emergency Fund

As our nation faces the COVID-19 pandemic, the importance of home-based child care has never been more evident and these caregivers and providers have never been more indispensable. We cannot fight this pandemic without ensuring that the essential workforce can access safe, high-quality child care. Without immediate action to maintain the supply of home-based child care, our near term efforts to rebuild the economy will likely be stalled.

FNDN
Mozilla COVID-19 Solutions Fund Rolling As part of the COVID-19 Solutions Fund, we will accept applications that are hardware (e.g., an open source ventilator), software (e.g., a platform that connects hospitals with people who have 3D printers who can print parts for that open source ventilator), as well as software that solves for secondary effects of COVID-19 (e.g., a browser plugin that combats COVID related misinformation). FNDN

Chan Zuckerberg Initiative

CZI COVID-19 Response Rolling Through our mission of supporting the science and technology that will make it possible to cure, prevent, or manage all diseases by the end of this century — we are already making an impact in helping scientists and researchers on the frontlines of this outbreak. The work of CZI’s team is aimed at leveraging open science, technology, and collaboration to accelerate our shared understanding of COVID-19. And in collaboration with our partners and across our network of grantees, CZI is helping fight this virus by increasing access to testing, genomic sequencing, research, community support, and more. FNDN

Novartis

Novartis COVID-19 Response Fund  To be announced Novartis today announced a broad set of measures to support the global response to the COVID-19 pandemic. These measures include the creation of a global fund to support communities around the world impacted by the COVID-19 pandemic as well as the company’s decision to join two key cross-industry R&D initiatives. FNDN
MusiCares

COVID-19 Relief Fund

Rolling

To help address the concerns of the industry during this time, we have expanded our services to include lost income due to the cancellation of scheduled gigs or performances due to Coronavirus/COVID-19 precautionary measures.

FNDN
Bill & Melinda Gates Foundation

COVID-19 Opportunity: COVID-19 Therapeutics Accelerator

To be announced

The Bill & Melinda Gates Foundation, Wellcome and Mastercard today committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. The COVID-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate term, and other viral pathogens in the longer-term. Currently, there are no broad-spectrum antivirals or immunotherapies available for the fight against emerging pathogens, and none approved for use on COVID-19.

FNDN
Patient-Centered Outcomes Research Institute (PCORI)

PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Research Projects

Rolling

PCORI seeks investigator-initiated proposals to address the COVID-19 public health crisis through enhancements of currently funded PCORI research awards.

Only PCORI-funded principal investigators with active research project funding contracts are eligible to submit a proposal in response to this announcement.

FNDN
Google

Google Cloud Research Credits

Rolling

A total of $20 million in Google Cloud research credits will be provided for leveraging Google’s computing capabilities and infrastructure to study therapies, vaccines, etc.

FNDN
Amgen Foundation

open donation request program

Rolling

Amgen has announced an open donation request program providing direct cash grants as well as lab supplies and equipment pertaining to COVID-19 relief; non-profits, IHEs, and health providers are welcome to apply. 

FNDN

CETF

Research for COVID-19 Treatments Rolling

Topics: CETF seeks research funding to find an existing drug or drug combination that, when given early, can reduce COVID-19 hospitalization and fatality rates by 75% or more

FNDN

West Coast Consortium for Technology & Innovation in Pediatrics (CTIP)

West Coast Consortium for Technology & Innovation in Pediatrics (CTIP)

Rolling

Topics: Pediatric medical device development or adaptation to manage the impact of COVID-19 on children

FNDN

 

Johnson & Johnson

Drug Resistant Tuberculosis Lifeline QuickFire Challenge

 

Topics: Proposals should address one or more of the following topics:

  • Remote consultations and follow-up
  • Home-based and/or digital patient support for sustaining TB treatment adherence & completion
  • Access to care for adverse events without leaving the home
  • Connections to support mental health, nutrition, address social isolation, and peer-to-peer support as well as social benefit
FNDN

23andMe

23andMe Research Innovation Collaborations Program for COVID-19

Rolling

23andMe is now considering proposals focused on COVID-19. These proposals can include studies of outcomes, comorbidities, health disparities, and impacts of policies implemented to address the pandemic. If your proposal is related to COVID-19, please be sure to indicate this in your application. We are anticipating a high volume of COVID-19-related proposals, and our team of scientific reviewers is committed to selecting proposals where 23andMe’s participation will uniquely advance our understanding of this disease and the health of those impacted.

FNDN

Women’s History Network

 Coronavirus hardship fund

This supports historians of women who are suffering financial hardship because of the coronavirus. A total of eight awards, worth £400 each, are available.

FNDN

Spanish Ministry of Science and Innovation

Solicitud Urgente de Expresiones de Interés para la Financiación Extraordinaria de Proyectos de Investigación sobre el SARS-CoV-2 y la Enfermedad COVID-19 (Spanish)

 

Rolling

 

Topics:

  • Scalable rapid diagnostic techniques for SARS-CoV-2, especially related to early stage detection and healthcare stratification
  • Clinical, biological, and molecular characteristics of COVID-19
  • Therapeutic development, including pharmaceutical and non-pharmaceutical measures
  • Antiviral resistance studies
  • Vaccine development
  • Socioeconomic impact of COVID-19
  • Integrated epidemiological controls, including AI and Big Data
INTL

Partnership for Advanced Computing in Europe

 

Support to mitigate the impact of COVID-19 pandemic

 This enables researchers to access computing resources to contribute to the mitigation of the impact of the COVID-19 pandemic. Access will be awarded for between three and six months and sized from 30 to 50 million core hours.

INTL

Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)

 

Emergency Action Projects to Combat the Effects of Covid-19 – FAPERJ / SES Partnership – 2020

Rolling

Topics:

  • Genomics
  • Pathophysiology of the disease
  • Clinical aspects
  • Diagnosis of the disease
  • Epidemiology
  • Virus-host interaction
  • Development of diagnostic kits
  • Disease control and coping strategies
  • Innovative solutions to expand supplies of items such as masks, alcohol gel, and respirators
INTL

National Research Council Canada

 

National Research Council Industrial Research Assistance Program (NRC IRAP)

 

Topics: Development of COVID-19 solutions for health care workers and public health officials

Due Dates: None; applicants directly contact an Industrial Technology Advisor at NRC

INTL